Brian Baranick - Aug 4, 2022 Form 3 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
Gen. Mgr., Precision Oncology
Signature
/s/ Brian Baranick by Mark R. Busch, attorney-in-fact
Stock symbol
EXAS
Transactions as of
Aug 4, 2022
Transactions value $
$0
Form type
3
Date filed
8/8/2022, 04:01 PM
Next filing
Feb 23, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding EXAS Common Stock 2.87K Aug 4, 2022 Direct
holding EXAS Common Stock 159 Aug 4, 2022 Held in 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding EXAS Restricted Stock Units Aug 4, 2022 Common Stock 8.14K Direct F1, F2
holding EXAS Restricted Stock Units Aug 4, 2022 Common Stock 5.19K Direct F2, F3
holding EXAS Restricted Stock Units Aug 4, 2022 Common Stock 15.8K Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit award that vests in three equal annual installments beginning on August 4, 2022.
F2 Each restricted stock unit represents a contingent right to receive one share of common stock.
F3 Represents a restricted stock unit award that vests in three equal annual installments beginning on February 19, 2023.
F4 Represents a restricted stock unit award that vests in four equal annual installments beginning on February 25, 2023.